Option exercise and block listing update
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Confirmation of Cancellation of Block Listing
CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, confirms that certain employees have exercised options under the Company's Save As You Earn (SAYE) 2020 scheme (the "SAYE Exercise") totalling 66,249 ordinary shares of 0.2 pence each ("Ordinary Shares") during January.
The SAYE Exercise was satisfied out of the Company's existing Employee Benefit Trust ("EBT") which was first announced on 28 February 2017. As at the date of this announcement, the remaining number of ordinary shares held by the EBT is 72,519.
The Company also announces that its 2015/2018 Save as You Earn option scheme has closed and, as a result, the block listing associated with it has been cancelled. Since the block listing interim review dated 24 June 2019, the Company issued a total of 24,335 shares in satisfaction of the exercise of SAYE options. All such issuance has been previously announced. The Company has no other block listings.
The Company's total issued share capital at the date of this announcement therefore remains unchanged at 70,654,959 Ordinary Shares each carrying one voting right.
The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,654,959. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
|
Name of applicant: |
CVS Group plc |
|||
|
Name of scheme: |
2015/2018 Save as You Earn Scheme |
|||
|
Period of return: |
From: |
23 June 2019 |
To: |
30 December 2019 |
|
Balance of unallotted securities under scheme(s) from previous return: |
136,632 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
24,335 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
112,297 |
|||
|
Subsequent cancellation: |
(112,297) |
|||
|
Equals: Remaining balance under block listing |
Nil |
|||
Contacts:
CVS Group Plc Tel: 01379 644288
Richard Fairman, Chief Executive Officer
David Harris, Company Secretary
N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000
Aubrey Powell (Corporate Finance)
Rachel Hayes (Corporate Broking)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Latest directors dealings
- 1 day ago Savannah Energy
- 1 day ago Buccaneer Energy PLC
- 1 day ago Savannah Energy
- 1 day ago Carclo
- 1 day ago Schroder Japan Growth Fund